Published ahead of print on August 15, 2002, doi:10.1164/rccm.200203-217OC
American Journal of Respiratory and Critical Care Medicine Vol 166. pp. 1475-1482, (2002)
© 2002 American Thoracic Society
Role of Interleukin-10 in the Intracellular Sequestration of Human Leukocyte Antigen-DR in Monocytes during Septic Shock
Thierry Fumeaux and
Jérôme Pugin
Departments of Internal Medicine, and Genetic and Microbiology, Division of Medical Intensive Care, and Faculty of Medicine, University Hospital of Geneva, Geneva, Switzerland
Correspondence and requests for reprints should be addressed to Jérôme Pugin, M.D., Division of Medical Intensive Care, University Hospital of Geneva, 24 rue Micheli-du-Crest, CH-1211 Geneva 14, Switzerland. E-mail: pugin{at}cmu.unige.ch
Monocytes from many critically ill patients show a low level of major histocompatibility complex type II (MHC II) expression. This phenomenon is believed to play a role in these patients' increased susceptibility to secondary infections. In the present study, we show that the level of monocyte human leukocyte antigen (HLA)-DR expression inversely correlates with the degree of severity of the sepsis syndrome. The defect of the monocyte HLA-DR expression resides in an intracellular sequestration of the MHC II molecules, a posttranslational effect. No significant decrease in the rate of transcription of HLA-DR, or its major transcriptional inducer, Class II transactivator, was noted. The levels of HLA-DR protein produced by monocytes from patients with septic shock were comparable to those from healthy volunteers. Plasma from patients with septic shock induced significant HLA-DR endocytosis resulting in decreased surface HLA-DR expression of normal donor monocytes. This effect was partially blocked by antiinterleukin (IL)-10 monoclonal antibody, but not by antagonists to transforming growth factor-ß1, prostaglandins, or ß-adrenergic agonists. Altogether, these data suggest that HLA-DR molecules are re-endocytosed and retained intracellularly in monocytes from patients with septic shock, and that this phenomenon is partially mediated by IL-10. IL-10 may represent a future target for immunomodulating patients with the sepsis syndrome or critically ill patients at risk of developing infections.
Key Words: human leukocyte antigen D Class II transactivator protein immune paralysis major histocompatibility complex type II genes antigen presentation
This article has been cited by other articles:

|
 |

|
 |
 
L. Calderon-Garciduenas, M. Franco-Lira, R. Torres-Jardon, C. Henriquez-Roldan, G. Barragan-Mejia, G. Valencia-Salazar, A. Gonzalez-Maciel, R. Reynoso-Robles, R. Villarreal-Calderon, and W. Reed
Pediatric Respiratory and Systemic Effects of Chronic Air Pollution Exposure: Nose, Lung, Heart, and Brain Pathology
Toxicol Pathol,
January 1, 2007;
35(1):
154 - 162.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Cavaillon and D. Annane
Invited review: Compartmentalization of the inflammatory response in sepsis and SIRS
Innate Immunity,
June 1, 2006;
12(3):
151 - 170.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Wunderink
Nosocomial Pneumonia, Including Ventilator-associatedPneumonia
Proceedings of the ATS,
December 1, 2005;
2(5):
440 - 444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bracci-Laudiero, L. Aloe, M. C. Caroleo, P. Buanne, N. Costa, G. Starace, and T. Lundeberg
Endogenous NGF regulates CGRP expression in human monocytes, and affects HLA-DR and CD86 expression and IL-10 production
Blood,
November 15, 2005;
106(10):
3507 - 3514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Cavaillon, C. Adrie, C. Fitting, and M. Adib-Conquy
Reprogramming of circulatory cells in sepsis and SIRS
Innate Immunity,
October 1, 2005;
11(5):
311 - 320.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gessler, R. Pretre, C. Burki, V. Rousson, B. Frey, and D. Nadal
Monocyte function-associated antigen expression during and after pediatric cardiac surgery
J. Thorac. Cardiovasc. Surg.,
July 1, 2005;
130(1):
54 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pugin, S. Stern-Voeffray, B. Daubeuf, M. A. Matthay, G. Elson, and I. Dunn-Siegrist
Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock
Blood,
December 15, 2004;
104(13):
4071 - 4079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Le Tulzo, C. Pangault, L. Amiot, V. Guilloux, O. Tribut, C. Arvieux, C. Camus, R. Fauchet, R. Thomas, and B. Drenou
Monocyte Human Leukocyte Antigen-DR Transcriptional Downregulation by Cortisol during Septic Shock
Am. J. Respir. Crit. Care Med.,
May 15, 2004;
169(10):
1144 - 1151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lekkou, M. Karakantza, A. Mouzaki, F. Kalfarentzos, and C. A. Gogos
Cytokine Production and Monocyte HLA-DR Expression as Predictors of Outcome for Patients with Community-Acquired Severe Infections
Clin. Vaccine Immunol.,
January 1, 2004;
11(1):
161 - 167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Schaaf, F. Boehmke, H. Esnaashari, U. Seitzer, H. Kothe, M. Maass, P. Zabel, and K. Dalhoff
Pneumococcal Septic Shock Is Associated with the Interleukin-10-1082 Gene Promoter Polymorphism
Am. J. Respir. Crit. Care Med.,
August 15, 2003;
168(4):
476 - 480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Critical Care Medicine in AJRCCM 2002
Am. J. Respir. Crit. Care Med.,
February 1, 2003;
167(3):
294 - 305.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Anti-inflammatory Cytokines May Play Key Role in Sepsis
Journal Watch Infectious Diseases,
December 20, 2002;
2002(1220):
17 - 17.
[Full Text]
|
 |
|

|
 |

|
 |
 
J.-M. Cavaillon
"Septic Plasma": An Immunosuppressive Milieu
Am. J. Respir. Crit. Care Med.,
December 1, 2002;
166(11):
1417 - 1418.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 American Thoracic Society
|
|
|